SANJIVANI PARANTERAL
|
SANJIVANI PARANTERAL Last 5 Year Financial Ratios History
[Standalone]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 4.51 | 4.85 | 1.67 | -2.90 | -3.50 |
| CEPS(Rs) | 5.40 | 5.72 | 2.68 | -1.08 | -1.52 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | -3.07 | -7.58 | -52.83 | -82.93 | -80.03 |
| Tax Rate(%) | 8.75 | 0.66 | -0.51 | 5.54 | 10.00 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 14.76 | 13.65 | 8.35 | -3.38 | -7.00 |
| EBIT Margin(%) | 14.91 | 16.34 | 6.00 | -7.05 | -7.84 |
| Pre Tax Margin(%) | 13.90 | 15.66 | 5.51 | -11.06 | -9.15 |
| PAT Margin (%) | 12.69 | 15.56 | 5.54 | -10.44 | -8.24 |
| Cash Profit Margin (%) | 15.18 | 18.37 | 8.89 | -3.89 | -3.57 |
| Performance Ratios | |||||
| ROA(%) | 22.96 | 25.80 | 8.13 | -10.16 | -9.62 |
| ROE(%) | - | - | - | - | - |
| ROCE(%) | - | - | 266.43 | -265.98 | - |
| Asset Turnover(x) | 1.81 | 1.66 | 1.47 | 0.97 | 1.17 |
| Sales/Fixed Asset(x) | 1.53 | 1.39 | 1.17 | 0.76 | 1.16 |
| Working Capital/Sales(x) | -2.47 | -2.20 | -0.53 | -0.32 | -0.51 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.65 | 0.72 | 0.85 | 1.32 | 0.87 |
| Receivable days | 35.46 | 67.67 | 54.78 | 69.98 | 76.45 |
| Inventory Days | 36.41 | 15.59 | 18.34 | 24.84 | 21.36 |
| Payable days | 247.38 | 326.74 | 263.55 | 460.61 | 288.77 |
| Valuation Parameters | |||||
| PER(x) | 9.18 | 13.51 | 6.59 | - | - |
| PCE(x) | 7.67 | 11.44 | 4.10 | -8.07 | -3.18 |
| Price/Book(x) | -13.49 | -8.64 | -0.21 | -0.10 | -0.06 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.23 | 2.32 | 2.20 | 3.29 | 2.02 |
| EV/Core EBITDA(x) | 7.05 | 11.92 | 23.03 | -670.29 | -63.57 |
| EV/EBIT(x) | 8.22 | 13.97 | 35.91 | -46.66 | -25.76 |
| EV/CE(x) | 2.08 | 3.89 | 2.87 | 3.43 | 2.82 |
| M Cap / Sales | 1.17 | 2.14 | 0.37 | 0.31 | 0.11 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 15.94 | 21.96 | 53.46 | -34.82 | 39.71 |
| Core EBITDA Growth(%) | 3.71 | 148.93 | 3,089.12 | 89.94 | 98.46 |
| EBIT Growth(%) | 4.15 | 231.05 | 233.47 | 41.45 | 96.28 |
| PAT Growth(%) | -6.91 | 241.47 | 183.08 | 17.35 | 96.10 |
| EPS Growth(%) | -6.91 | 190.24 | 157.67 | 17.35 | 96.10 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | -0.81 | -0.79 | -1.03 | -1.00 | -1.02 |
| Current Ratio(x) | 0.36 | 0.35 | 0.16 | 0.07 | 0.12 |
| Quick Ratio(x) | 0.13 | 0.27 | 0.14 | 0.04 | 0.11 |
| Interest Cover(x) | 14.78 | 23.88 | 12.21 | -1.76 | -5.99 |
| Total Debt/Mcap(x) | 0.06 | 0.09 | 4.93 | 9.53 | 16.88 |
Compare Financial Ratios of peers of SANJIVANI PARANTERAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SANJIVANI PARANTERAL | ₹217.8 Cr | 0.6% | 10.4% | 232.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹367,290.0 Cr | -0.9% | 0.9% | 62.6% | Stock Analytics | |
| CIPLA | ₹113,357.0 Cr | 3.5% | 4.2% | 51.8% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹111,134.0 Cr | 12.2% | 18% | 103.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹104,235.0 Cr | 0.8% | 5.6% | 19.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,001.5 Cr | -1% | -2.4% | 28.4% | Stock Analytics | |
SANJIVANI PARANTERAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SANJIVANI PARANTERAL | 0.6% |
10.4% |
232.4% |
| SENSEX | 1.7% |
1.5% |
18.7% |
You may also like the below Video Courses
